Dendreon (DNDN) – Hot FDA News
-
Committee Recommends J&J's (JNJ) ZYTIGA Study Be Unblinded Amid Better Survival Data
-
Dendreon (DNDN) Announces CMS Will Now Cover Costs Related to Administration of PROVENGE
-
-
-
-
Back to DNDN Stock Lookup